Kazia Therapeutics – overview and update with CEO James Garner

Kazia Therapeutics – overview and update with CEO James Garner

Kazia Therapeutics — 9 videos in collection

More on this equity

Kazia Therapeutics (KZA) is an oncology-focused drug development company. Its drug candidates are designed to treat diseases which are poorly served by existing therapies. In this video, James Garner, CEO, highlights the company’s business model, newest drug asset and progress over the next year.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free